
Article
Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis
Rheumatology
(2018)
Disciplines
Publication Date
November 1, 2018
DOI
10.1093/rheumatology/key173
Citation Information
Mark C Genovese, Michael E Weinblatt, Philip J Mease, Jacob A Aelion, et al.. "Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis" Rheumatology Vol. 57 Iss. 11 (2018) p. 1972 - 1981 Available at: http://works.bepress.com/philip-mease/354/